Kendle will add OmniComm’s TrialMaster EDC solution to its eClinical offerings
OmniComm Systems has announced that Kendle will add OmniComm’s TrialMaster EDC solution to its current eClinical offerings in a multi-year enterprise-wide agreement.
John Fontenault, executive director and global head of clinical data management and technology at Kendle, said: Efficient delivery of high-quality data is critical to Kendle’s continued success as a leading provider of clinical data management services. The addition of the TrialMaster EDC solution to our existing offerings supports Kendle’s focus on providing our global biopharmaceutical customers with cost-effective access to the best eClinical solutions to accelerate their phase I through IV clinical trials. The TrialMaster platform offers the right mix of functionality to streamline the study development process and drive efficient study operations.
Stephen Johnson, COO of OmniComm Systems, said: We are excited to be working with Kendle to meet the needs of its diverse customer base. Kendle is one of the largest and most respected and successful top-tier global CROs with extensive eClinical experience, having conducted more than 250 trials utilizing EDC technologies to expedite the clinical trials process. We look forward to providing them the eClinical solutions and services needed to support their continued delivery of best-in-class clinical development services to their customers.
Kendle International is a clinical research organisation providing full range of early- to late-stage clinical development services for the biopharmaceutical industry.
Fort Lauderdale-based, OmniComm Systems provides Internet solutions to pharmaceutical, biotechnology, research and medical device organisations that conduct clinical trial research.